DE GARIDEL MARC (Chief Executive Officer) reported 2 transactions at CINCOR PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2023ACC: 0001209191-23-012890
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-1.54M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
1.54M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−12.50K
Price / share
—
Trade value
—
% of position
5.9%
2/24/2023
212.50K→200K
Common Stock
Direct
Shares
−200K
Price / share
—
Trade value
—
% of position
New position
2/24/2023
200K→0.00
Total
Net shares
−212.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2023 | U · U | −12.50K | — | — | 5.9% | 212.50K | 200K |
| Common Stock Direct | 2/24/2023 | D · Disposition | −200K | — | — | New position | 200K | 0.00 |
| Total | −212.50K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
726.48K shares
Shares
−726.48K
Strike price
5.82
Held after
0.00
Exercisable
—
2/24/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
601.90K shares
Shares
−601.90K
Strike price
7.62
Held after
0.00
Exercisable
—
2/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock726.48K shares | 2/24/2023 | D · Disposition | −726.48K | 5.82 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock601.90K shares | 2/24/2023 | D · Disposition | −601.90K | 7.62 | — | 0.00 |